Skip to main content


AI-powered Continuous Intelligence is transforming European Launch Strategy by helping pharmaceutical teams prepare for EU HTA, optimize reimbursement planning, and monitor competitor activity in real time. This case study shows how Market Access Intelligence supports stronger evidence generation, better payer engagement, and more informed commercialization decisions across Europe's evolving healthcare landscape.